Navigation Links
Pfizer Hemophilia presents new data at the World Federation of Hemophilia 2010 Congress
Date:7/8/2010

BUENOS AIRES, ARGENTINA, July 9 Pfizer Inc, the world's leading biopharmaceutical company, today announced that the results of a number of hemophilia studies will be presented at the World Federation of Hemophilia (WFH) 2010 Congress taking place July 10-14, 2010, in Buenos Aires, Argentina. Key research includes a pre-clinical evaluation of recombinant factor Xa as a potential new approach to restoring hemostasis, as well as a study assessing the potential for an engineered recombinant factor VIIa molecule to improve therapeutic outcomes in mouse models of hemophilia. These presentations follow Pfizer's recent announcement about the creation of a new research unit focused on rare diseases, including hemophilia.

"We are very excited to present these data, which highlights the strength of our pipeline and our enduring commitment to provide recombinant products for the hemophilia community," says Brenda Cooperstone, M.D., vice president of clinical development and medical affairs for the Specialty Care Business Unit at Pfizer. "Our investigation of novel therapies for hemophilia treatment remains ongoing and we will continue to work closely with our partnersincluding the World Federation of Hemophiliato help improve hemophilia care worldwide."

Early Research with Factor Xa and VIIa

Pfizer will present the results of a pre-clinical study in mice indicating that recombinant factor Xa therapy may provide a unique way to bypass deficiencies in the intrinsic pathway. Additional results from a preclinical study in mice suggest that a recombinant factor VIIa molecule with increased activity and duration of action may have the potential to improve inhibitor outcomes.

Additional Hemophilia Research from Pfizer at WFH

  • New model of antibody-induced hemophilia A for the assessment of bypass therapies
  • An electronic documentation system in Haemophilia provides otherwise unavailable feedback for continuous qua
    '/>"/>

Contact: Gwen Fisher
Gwen.Fisher@Pfizer.com
484-865-5160
Edelman Public Relations
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Pfizer joins open-access medicinal chemistry public-private collaboration
2. VIDEO from Medialink and National Fibromyalgia Association and Pfizer Inc.: The Science Behind Fibromyalgia
3. Sigma-Aldrich Reaches Agreement to Sell Pfizers Bioactive Small Molecule Compounds
4. Arizona Myeloma Network presents Special Award to TGen president
5. ItsHot.com Presents Aesthetic Diamond Jewelry and Diamond Watches at Wholesale Prices
6. Morehead Presents Webinar on “Managing the Paradox of Employee Alignment and Engagement”
7. RockWest Technology Group Presents Campus Contactless Card Technology at NACCU
8. NextAid Presents BIDS BUILD HOPE Online Auction to Benefit Projects on the Ground in Africa on World AIDS Orphans Day
9. Morehead Presents Webinar on “Creating a High-Performing RN Workforce”
10. AllianceDiamonds.com Presents: Facebook Diamond Giveaway 2010
11. Aderans Research Presents at SID (Society of Investigative Dermatology)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... According to Transparency Market Research “Endoscopy devices ... and Forecast, 2011 – 2017,” the global endoscopy devices ... 2011 and is expected to reach USD 10.8 billion ... 2011 to 2017. Flexible endoscopes formed the largest category ... million for the year 2011. , Related Report : ...
(Date:6/19/2013)... is many fold higher in persons over 65 years ... how best to treat these older cancer patients. Furthermore, ... trials, those elderly patients who are eventually included are ... patient population is not well represented in clinical trials. ... now starting a new phase 2 trial in precisely ...
(Date:6/19/2013)... 2013 Ethigen announced today the US ... service , providing next-generation sequencing (NGS) and rearrangement analysis ... part of an expanded hereditary cancer panel, including full ... links to cancer risk: MLH1, MSH2, MSH6, APC, MUTYH ... FH, FLCN, PDGFRA, and KIT. , The expanded ...
(Date:6/19/2013)... Angeles, California (PRWEB) June 19, 2013 ... for iPhone, a free music and fitness app for ... you can discover new Spotify songs that match your ... when they exercise, and add songs to your favorite ... and songs curated by the GoTunes staff. , Get ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 The reason for ... is because users can place a 4x8 flood tray inside ... space to work around. In addition, Gorilla Grow Tents ... they are the tallest, thickest and strongest grow tents on ... for grow tent standards. , Gorilla Grow Tents ...
Breaking Medicine News(10 mins):Health News:Endoscopy Devices Market Will Reach USD 10.8 Billion in 2017 : Transparency Market Research 2Health News:Endoscopy Devices Market Will Reach USD 10.8 Billion in 2017 : Transparency Market Research 3Health News:EORTC study opens for elderly patients with HER-2 positive metastatic breast cancer 2Health News:Ethigen Launches Next Generation (NGS) BRCA Testing With Expanded Hereditary Cancer Panel 2Health News:Ethigen Launches Next Generation (NGS) BRCA Testing With Expanded Hereditary Cancer Panel 3Health News:The GoTunes Iphone App Creates a Streaming Workout Music Community Via Spotify 2Health News:Stealth Grow Tent Brand’s Popularity Rises 2
... , , , , , ... -- Mindray Medical,International Limited (NYSE: MR ), a ... shareholder resolutions,adopted at its annual general meeting of shareholders held ... At the meeting, Mindray Medical International,s shareholders approved the,re-election ...
... finds , FRIDAY, Dec. 18 (HealthDay News) -- Long-term ... may not be able to regain full stability while ... gait and balance become stable. However, even with prolonged ... difficulty in standing upright. Their balance can be marked ...
... Dec. 18 Memorial Blood Centers is pleased to have ... 22, 2009 at the City of Duluth Employees Blood Drive. Following ... be an open house at Memorial Blood Centers in Duluth from ... aging and unreliable bloodmobile and will allow Memorial Blood Centers to ...
... , WASHINGTON, Dec. 18 Since ... largely by the U.S. Agency for International Development (USAID), ... critical insight for decision makers to plan, monitor, and ... staff has helped conduct some 260 surveys in over ...
... blacks, study finds , FRIDAY, Dec. 18 (HealthDay News) -- ... are more likely to skip taking their meds, a new ... patients, aged 60 and older, who were interviewed at the ... year later. , Overall, whites used more medications, had more ...
... CentraCare president is new chair , ST. PAUL, Minn., ... health systems, recently elected or re-elected the following members to its board ... Chair - Terence Pladson, M.D., president, CentraCare Health System, ... Klimp, CEO, Queen of Peace Hospital, New Prague, Secretary/treasurer ...
Cached Medicine News:Health News:Mindray Medical International Limited Announces Shareholder Resolutions Adopted at 2009 Annual General Meeting 2Health News:Alcoholics May Never Fully Regain Balance 2Health News:Memorial Blood Centers Showcases New Vehicle 2Health News:USAID Celebrates 25 Years of Demographic and Health Surveys 2Health News:Medication Adherence Varies Between Races 2Health News:Minnesota Hospital Association Elects, Re-Elects Members to Board 2
(Date:6/18/2013)... 18, 2013  Intercept Pharmaceuticals, Inc.  (NASDAQ: ... the development and commercialization of novel bile acid therapeutics ... of an underwritten public offering of 1,730,000 shares of ... $33.01 per share.  In addition, Intercept has granted the ... additional 259,500 shares of common stock. All ...
(Date:6/18/2013)... PROSPECT, Ill. , June 18, 2013 /PRNewswire-iReach/ ... of its new X3130 Appliance Inlet Module. The ... circuit breaker , combines a C14 appliance inlet ... one compact package.  This three-in-one device allows design ... their designs - cutting installation time by 66 ...
(Date:6/18/2013)... June 18, 2013  It has become apparent ... Seating and Mobility, a subsidiary company of The ... repair. This appears to be due to the ... field service employees.  (Logo: ... of these clients are complex mobility users with ...
Breaking Medicine Technology:Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2Three-in-One X3130 Appliance Inlet Module 2
... Nov. 29, 2011 Uptake Medical® today announced the ... lung volume reduction in a patient with severe emphysema. ... endoscopic lung volume reduction system for the treatment of ... without leaving foreign materials in the lung. The patient ...
... IRVING, Texas, Nov. 29, 2011 A new study in ... has uncovered a novel mechanism that cancer cells may use ... "Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T ... Moffitt Cancer Center in Tampa, Fla., shows that a specific ...
Cached Medicine Technology:Uptake Medical Announces First Commercial Use of InterVapor for Patients With Severe Emphysema 2Uptake Medical Announces First Commercial Use of InterVapor for Patients With Severe Emphysema 3New Study Points to Novel Mechanism by Which Tumors Escape Recognition by the Immune System 2New Study Points to Novel Mechanism by Which Tumors Escape Recognition by the Immune System 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: